News
Valneva shares tumble after suspension of US chikungunya vaccine licence
Shares of French drugmaker Valneva slumped more than 20% on Monday after the U.S. Food and Drug Administration suspended the licence for its chikungunya vaccine, Ixchiq, with immediate effect, citing serious safety concerns.
Valneva Shares Tumble After Chikungunya Vaccine License Suspended in U.S.
Valneva shares dropped after it said it will no longer be able to sell its chikungunya vaccine in the U.S. after reports linked the vaccine to adverse effects. Shares trading in New York were nearly 22% lower ahead of the morning bell at $9.
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is ...
The US Food and Drug Administration (FDA) announced late last week that it has suspended the license for French drugmaker ...
Mosquito-borne chikungunya virus has caused an outbreak in China, but public health experts say the risk for spread and ...
The U.S. Centers for Disease Control and Prevention has issued a travel warning following an outbreak of a mosquito-borne ...
8don MSN
What is chikungunya virus? Symptoms and advice as cases rise among travellers returning to UK
What is chikungunya virus? Symptoms and advice as cases rise among travellers returning to UK - UK health authorities have ...
An outbreak of the mosquito-borne virus in southern China has led to a pandemic-style response as authorities try to contain ...
Thousands in southern China have been infected with a mosquito-borne illness in the past few weeks, in what's considered one ...
Health agencies recommend wearing insect repellent and loose-fitting clothing to prevent bites from mosquitoes carrying the ...
DEAR DR. ROACH: I have a friend who lives in Paraguay and had been diagnosed with chikungunya. It has been extremely painful ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback